RuzzarinAMuragliaSFabrisECarettaGZilioFPezzatoA. Impact of contrast-associated acute kidney injury on one-year outcomes in very elderly STEMI patients: insights from a multicenter registry in Northern Italy. Angiology. 2025;76(9):886-893.
2.
TumminelloGD'ErricoAMaruccioAGentileDBarbieriLCarugoS. Age-Related Mortality in STEMI Patients: Insight from One Year of HUB Centre Experience during the Pandemic. J Cardiovasc Dev Dis. 2022;9:43.
3.
AlexanderKPNewbyLKArmstrongPW, et al.Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: In collaboration with the Society of Geriatric Cardiology. Circulation. 2007;115:2570-2589.
4.
VerdoiaMGiosciaRViolaO, et al.Novara Atherosclerosis Study Group (NAS). Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention. J Cardiovasc Med (Hagerstown). 2023;24:631-636.
5.
TashiroHTanakaATakagiKN-registry investigators, et al.Incidence and predictors of frailty progression among octogenarians with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Arch Gerontol Geriatr. 2022;102:104737.
6.
De LucaGVerdoiaMMoriciN, et al.Elderly ACS 2 Investigators. Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial. Int J Cardiol. 2022;369:5-11.
7.
MontaltoCCrimiGMoriciN, et al.Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores. Int J Cardiol. 2021;328:22-28.
8.
SavonittoSDe ServiS. Early invasive approach and outcome in elderly patients with NSTEACS: randomised trials, real-world data and guideline recommendations. EuroIntervention. 2021;17:20-21.
9.
BergESTegnNKAbdelnoorM, et al.After Eighty Study Investigators. Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol. 2023;82:2021-2030.
10.
van den BroekWWAGimbelMEChanPYinD. Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry. J Clin Med. 2023;12:5450.
11.
CosentinoNRestaMLSomaschiniA, et al.Acute kidney injury and in-hospital mortality in patients with ST-elevation myocardial infarction of different age groups. Int J Cardiol. 2021;344:8-12.
12.
LenhardDCPietschHSieberMAErnstRLengsfeldPEllinghausPJostG. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. Invest Radiol. 2012;47(9):503-510.
13.
LeeTKimWKKimAJRoHChangJHLeeHHChungWJungJY. Low-Osmolar vs. Iso-Osmolar Contrast Media on the Risk of Contrast-Induced Acute Kidney Injury: A Propensity Score Matched Study. Front Med (Lausanne). 2022;9:862023
14.
QiuHZhuYShenGWangZLiW. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction. Clin Interv Aging. 2023;18:453-465.
15.
MehranRAymongEDNikolskyE, et al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399.
16.
DodsonJAHajdukACurtisJ, et al.Acute kidney injury among older patients undergoing coronary angiography for acute myocardial infarction: the SILVER-AMI Study. Am J Med. 2019;132:e817-e826.
